Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. (2016)

First Author: Todd JA
Attributed to:  Adaptive Clinical Trials funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 27727279

Publication URI:

Type: Journal Article/Review

Volume: 13

Parent Publication: PLoS medicine

Issue: 10

ISSN: 1549-1277